Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

The global Therapeutic Radioisotopes market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Therapeutic Radioisotopes volume and value at global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Radioisotopes market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other

Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other